The good news about Alzheimer’s disease | UW Medicine Newsroom

Progression can be slowed

  • Wednesday, January 31, 2018 1:29pm
  • Life

Alzheimer’s disease is latent in the brain and there are ways to intervene and prevent it from progressing.

Here’s the good news. Alzheimer’s is a slow-growing disease that can lay latent for 15 years before developing into dementia and research suggests there are ways to slow the disease’s progression, according to a UW Medicine Newsroom blog.

This comes from Thomas Grabowski, professor of radiology and neurology at the University of Washington School of Medicine. He directs the UW Memory and Brain Wellness Center and the UW Alzheimer’s Research Disease Center.

“Alzheimer’s is the last stage of a process that has been going on for years,” he said. “Before dementia, there is a stage called mild-cognitive impairment when people have mild difficulties that don’t interfere with daily living. And before that, there’s a period of time, at least 15 years, that Alzheimer’s disease is latent in the brain and slowly advancing. That’s our opportunity for intervention and prevention.”

Grabowski said you will hear about clinical trials in which researchers are looking for people with asymptomatic biomarkers. One is called the EARLY trial, a national multi-centered trial where people are given a beta secretase inhibitor, a daily pill that prevents buildup of amyloid protein in the brain. UW is one of the sites. The idea is this pill would prevent the asymptomatic patients from advancing to a mildly cognitive impaired stage.

Lifestyle interventions also play a big role.

“What you do during your midlife in terms of your cognitive lifestyle, your aerobic exercise, your social connectedness all play into the success of your brain aging,” he said.

Currently, there is no FDA-approved medication to reverse Alzheimer’s but trials are ongoing. The national goal is to cure Alzheimer’s by 2025 and the National Institutes of Health has prioritized funding that research.

Another ongoing trial is the Biogen EMERGE study of an Alzheimer’s antibody, adjucanumab, that removes amyloid protein from the brain. The medicine is given once a month intravenously. More than 1,100 patients are enrolled nationally and UW Medicine is one of the sites. Grabowski said preliminary studies have been encouraging, but the results need to be statistically relevant.

As for supplements, Grabowski said with people with early stages of Alzheimer’s, there is evidence that fish oil can improve brain health.

More in Life

Hillsong United coming to Kent’s ShoWare Center May 30

Christian worship band from Australia

‘Bah! Humbug!’ Scrooge comes to local stage

The familiar words uttered by Ebenezer Scrooge have a spirited ring to… Continue reading

Kent Library programming | KCLS | December

Libraries Kent Public Library: 212 2nd Avenue N., Kent. 253-859-3330. Hours: 10… Continue reading

Auburn Symphony Orchestra to perform holiday concert Dec. 17

Featuring guest soprano Rachel DeShon and ASO concertmaster Brittany Boulding on electric violin

This book is sure to put you in the Christmas mood

You thought you knew what was inside the box. Though it was… Continue reading

Magical Strings will perform at 3 p.m. Sunday, Dec. 2 at the Kent-Meridian Performing Arts Center. COURTESY PHOTO
Magical Strings to perform in Kent on Dec. 2

Group celebrates 40 years of annual Celtic Yuletide Concerts

Kent man wins State Make It With Wool contest

John Yingling, of Kent, was named State Alternate Adult Winner at the… Continue reading

Winterfest to light up Kent Town Square Plaza on Saturday, Dec. 1

Festivites include music, visit from Santa and Christmas tree lighting ceremony

Photos, maps, fun facts make this book addicting

You know? Of course you do, because you’re no dummy. You’re on… Continue reading

Auburn Symphony Orchestra Chamber Series comes to Kent, Auburn

Musicians to perform works by Beethoven, Britten and Loeffler